SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Rachel M. McQuade, Joel C. Bornstein, Kulmira Nurgali, Anti-Colorectal Cancer Chemotherapy-Induced Diarrhoea: Current Treatments and Side-Effects, International Journal of Clinical Medicine, 2014, 05, 07, 393

    CrossRef

  2. 2
    R. Velasco, J. Bruna, C. Briani, A. A. Argyriou, G. Cavaletti, P. Alberti, B. Frigeni, M. Cacciavillani, S. Lonardi, D. Cortinovis, M. Cazzaniga, C. Santos, H. P. Kalofonos, Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients, Journal of Neurology, Neurosurgery & Psychiatry, 2014, 85, 4, 392

    CrossRef

  3. 3
    Hak Jin Moon, Bong-Soo Lim, Dae-Il Lee, Min Sook Ye, Giseog Lee, Byung-Il Min, Hyunsu Bae, Heung Sik Na, Sun Kwang Kim, Effects of electroacupuncture on oxaliplatin-induced neuropathic cold hypersensitivity in rats, The Journal of Physiological Sciences, 2014, 64, 2, 151

    CrossRef

  4. 4
    L.M. Buffart, D.A. Galvão, J. Brug, M.J.M. Chinapaw, R.U. Newton, Evidence-based physical activity guidelines for cancer survivors: Current guidelines, knowledge gaps and future research directions, Cancer Treatment Reviews, 2014, 40, 2, 327

    CrossRef

  5. 5
    Masahiro Ohsawa, Saki Otake, Tomoyasu Murakami, Shohei Yamamoto, Toshiaki Makino, Hideki Ono, Gabapentin Prevents Oxaliplatin-Induced Mechanical Hyperalgesia in Mice, Journal of Pharmacological Sciences, 2014, 125, 3, 292

    CrossRef

  6. 6
    Keita Mizuno, Toru Kono, Yasuyuki Suzuki, Chika Miyagi, Yuji Omiya, Kanako Miyano, Yoshio Kase, Yasuhito Uezono, Goshajinkigan, a Traditional Japanese Medicine, Prevents Oxaliplatin-Induced Acute Peripheral Neuropathy by Suppressing Functional Alteration of TRP Channels in Rat, Journal of Pharmacological Sciences, 2014, 125, 1, 91

    CrossRef

  7. 7
    Byung-Soo Ahn, Seong-Kyu Kim, Ha Neul Kim, Ji-Hye Lee, Ji-Hwan Lee, Deog Sang Hwang, Hyunsu Bae, Byung-Il Min, Sun Kwang Kim, Gyejigachulbu-Tang Relieves Oxaliplatin-Induced Neuropathic Cold and Mechanical Hypersensitivity in Rats via the Suppression of Spinal Glial Activation, Evidence-Based Complementary and Alternative Medicine, 2014, 2014, 1

    CrossRef

  8. 8
    Alexander G. Dimitrov, Nonna A. Dimitrova, Internodal mechanism of pathological afterdischarges in myelinated axons, Muscle & Nerve, 2014, 49, 1
  9. 9
    Lixin Yang, Haihua Xiao, Lesan Yan, Rui Wang, Yubin Huang, Zhigang Xie, Xiabin Jing, Lactose targeting oxaliplatin prodrug loaded micelles for more effective chemotherapy of hepatocellular carcinoma, Journal of Materials Chemistry B, 2014, 2, 15, 2097

    CrossRef

  10. 10
    María Sereno, Gerardo Gutiérrez-Gutiérrez, César Gómez-Raposo, Miriam López-Gómez, Maria Merino-Salvador, Francisco Zambrana Tébar, Cristina Rodriguez-Antona, Enrique Casado, Oxaliplatin induced-neuropathy in digestive tumors, Critical Reviews in Oncology/Hematology, 2014, 89, 1, 166

    CrossRef

  11. 11
    Roser Velasco, Jordi Bruna, Oxaliplatin Neurotoxicity, Current Colorectal Cancer Reports, 2014, 10, 3, 303

    CrossRef

  12. 12
    Nathan P. Staff, Anthony J. Windebank, Peripheral Neuropathy Due to Vitamin Deficiency, Toxins, and Medications, CONTINUUM: Lifelong Learning in Neurology, 2014, 20, 1293

    CrossRef

  13. You have free access to this content13
    Susanna B. Park, David Goldstein, Arun V. Krishnan, Cindy S-Y Lin, Michael L. Friedlander, James Cassidy, Martin Koltzenburg, Matthew C. Kiernan, Chemotherapy-induced peripheral neurotoxicity: A critical analysis, CA: A Cancer Journal for Clinicians, 2013, 63, 6
  14. You have free access to this content14
    Andreas A. Argyriou, Guido Cavaletti, Chiara Briani, Roser Velasco, Jordi Bruna, Marta Campagnolo, Paola Alberti, Francesca Bergamo, Diego Cortinovis, Marina Cazzaniga, Cristina Santos, Konstantinos Papadimitriou, Haralabos P. Kalofonos, Clinical pattern and associations of oxaliplatin acute neurotoxicity, Cancer, 2013, 119, 2
  15. 15
    John M. Kirkwood, Ahmad Tarhini, Joseph A. Sparano, Prapti Patel, Joan H. Schiller, Maxwell T. Vergo, Al B. Benson III, Hussein Tawbi, Comparative clinical benefits of systemic adjuvant therapy for paradigm solid tumors, Cancer Treatment Reviews, 2013, 39, 1, 27

    CrossRef

  16. 16
    Hani A. Kushlaf, Emerging Toxic Neuropathies and Myopathies, Psychiatric Clinics of North America, 2013, 36, 2, 209

    CrossRef

  17. 17
    Yanyun Zhu, Junlan Yang, Shunchang Jiao, Tiefeng Ji, Ganglioside-monosialic acid (GM1) prevents oxaliplatin-induced peripheral neurotoxicity in patients with gastrointestinal tumors, World Journal of Surgical Oncology, 2013, 11, 1, 19

    CrossRef

  18. 18
    Catherine H Han, Prashannata Khwaounjoo, Dean H Kilfoyle, Andrew Hill, Mark J McKeage, Phase I drug-interaction study of effects of calcium and magnesium infusions on oxaliplatin pharmacokinetics and acute neurotoxicity in colorectal cancer patients, BMC Cancer, 2013, 13, 1, 495

    CrossRef

  19. 19
    Hadi Manji, Peripheral Nerve Disorders, 2013,

    CrossRef

  20. 20
    Alexander G. Dimitrov, Nonna A. Dimitrova, A possible link of oxaliplatin-induced neuropathy with potassium channel deficit, Muscle & Nerve, 2012, 45, 3
  21. 21
    Ju Young YOON, Tai Seung NAM, Myeong Kyu KIM, Jun Eul HWANG, Hyun-Jeong SHIM, Sang Hee CHO, Ik Joo CHUNG, Woo Kyun BAE, Acute inflammatory demyelinating polyradiculoneuropathy in a patient receiving oxaliplatin-based chemotherapy, Asia-Pacific Journal of Clinical Oncology, 2012, 8, 2
  22. 22
    Elisabeth Krexner, Anika Stickler, Christian Prainer, Josef Finsterer, Acute, generalised but transient muscle cramping and weakness shortly after first oxaliplatin infusion, Medical Oncology, 2012, 29, 5, 3592

    CrossRef

  23. 23
    R. Sittl, A. Lampert, T. Huth, E. T. Schuy, A. S. Link, J. Fleckenstein, C. Alzheimer, P. Grafe, R. W. Carr, Anticancer drug oxaliplatin induces acute cooling-aggravated neuropathy via sodium channel subtype NaV1.6-resurgent and persistent current, Proceedings of the National Academy of Sciences, 2012, 109, 17, 6704

    CrossRef

  24. 24
    Andreas A. Argyriou, Jordi Bruna, Paola Marmiroli, Guido Cavaletti, Chemotherapy-induced peripheral neurotoxicity (CIPN): An update, Critical Reviews in Oncology/Hematology, 2012, 82, 1, 51

    CrossRef

  25. 25
    Karine Thibault, Bernard Calvino, Sophie Dubacq, Marie Roualle-de-Rouville, Vallier Sordoillet, Isabelle Rivals, Sophie Pezet, Cortical effect of oxaliplatin associated with sustained neuropathic pain: Exacerbation of cortical activity and down-regulation of potassium channel expression in somatosensory cortex, Pain, 2012, 153, 8, 1636

    CrossRef

  26. 26
    Jung Lee, Yoon Kim, Eun Jeon, Hye Won, Young-Seok Cho, Yoon Ko, Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats, BMC Complementary and Alternative Medicine, 2012, 12, 1, 124

    CrossRef

  27. 27
    Cindy Tofthagen, Janine Overcash, Kevin Kip, Falls in persons with chemotherapy-induced peripheral neuropathy, Supportive Care in Cancer, 2012, 20, 3, 583

    CrossRef

  28. 28
    Zhenjie Wu, Jun Ouyang, Zhenhua He, Sen Zhang, Infusion of calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in colorectal cancer: A systematic review and meta-analysis, European Journal of Cancer, 2012, 48, 12, 1791

    CrossRef

  29. 29
    Brett Morrison, Vinay Chaudhry, Medication, Toxic, and Vitamin-Related Neuropathies, CONTINUUM: Lifelong Learning in Neurology, 2012, 18, 139

    CrossRef

  30. 30
    Catherine HAN, Mark MCKEAGE, Neuropathies associated with oxaliplatin therapy, Asia-Pacific Journal of Clinical Oncology, 2012, 8, 2
  31. 31
    Toru Kono, Machiko Satomi, Manabu Suno, Norihisa Kimura, Hirotaka Yamazaki, Hiroyuki Furukawa, Kazuo Matsubara, Oxaliplatin-induced neurotoxicity involves TRPM8 in the mechanism of acute hypersensitivity to cold sensation, Brain and Behavior, 2012, 2, 1
  32. 32
    X.F. Chen, R. Wang, Y.M. Yin, O.D. Røe, J. Li, L.J. Zhu, R.H. Guo, Ting Wu, Y.Q. Shu, The effect of monosialotetrahexosylganglioside (GM1) in prevention of oxaliplatin induced neurotoxicity: A retrospective study, Biomedicine & Pharmacotherapy, 2012, 66, 4, 279

    CrossRef

  33. 33
    T.J. Postma, J.J. Heimans, Neuro-Oncology Part II, 2012,

    CrossRef

  34. 34
    Robert Raffa, Joseph Pergolizzi, Chemotherapy-Induced Neuropathic Pain, 2012,

    CrossRef

  35. 35
    Djane Braz Duarte, Michael R. Vasko, DNA Repair in Cancer Therapy, 2012,

    CrossRef

  36. 36
    Susanna B. Park, Cindy S.-Y. Lin, Arun V. Krishnan, Michael L. Friedlander, Craig R. Lewis, Matthew C. Kiernan, Early, progressive, and sustained dysfunction of sensory axons underlies paclitaxel-induced neuropathy, Muscle & Nerve, 2011, 43, 3
  37. 37
    Hani A. Kushlaf, Emerging Toxic Neuropathies and Myopathies, Neurologic Clinics, 2011, 29, 3, 679

    CrossRef

  38. 38
    Hironori Fujii, Hirotoshi Iihara, Koji Yasuda, Katsuhiko Matsuura, Takao Takahashi, Kazuhiro Yoshida, Yoshinori Itoh, Evaluation of efficacy and safety of generic levofolinate in patients who received colorectal cancer chemotherapy, Medical Oncology, 2011, 28, 2, 488

    CrossRef

  39. 39
    Michele Basso, Anna Modoni, Mauro Lo Monaco, Carlo Barone, In reply, Cancer Chemotherapy and Pharmacology, 2011, 67, 5, 1191

    CrossRef

  40. 40
    Cynthia L Renn, Valentina A Carozzi, Peter Rhee, Danisha Gallop, Susan G Dorsey, Guido Cavaletti, Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice, Molecular Pain, 2011, 7, 1, 29

    CrossRef

  41. 41
    Pedro Alvarez, Luiz F. Ferrari, Jon D. Levine, Muscle pain in models of chemotherapy-induced and alcohol-induced peripheral neuropathy, Annals of Neurology, 2011, 70, 1
  42. 42
    Romina Nassini, Maarten Gees, Selena Harrison, Gaetano De Siena, Serena Materazzi, Nadia Moretto, Paola Failli, Delia Preti, Nicola Marchetti, Alberto Cavazzini, Francesca Mancini, Pamela Pedretti, Bernd Nilius, Riccardo Patacchini, Pierangelo Geppetti, Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation, Pain, 2011, 152, 7, 1621

    CrossRef

  43. 43
    Cindy Tofthagen, R. Denise McAllister, Susan C. McMillan, Peripheral Neuropathy in Patients With Colorectal Cancer Receiving Oxaliplatin, Clinical Journal of Oncology Nursing, 2011, 15, 2, 182

    CrossRef

  44. 44
    Michele Basso, Anna Modoni, Daniele Spada, Alessandra Cassano, Giovanni Schinzari, Mauro Lo Monaco, Davide Quaranta, Pietro Attilio Tonali, Carlo Barone, Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity, Cancer Chemotherapy and Pharmacology, 2011, 67, 5, 1179

    CrossRef

  45. 45
    Edward J. Dropcho, The Neurologic Side Effects of Chemotherapeutic Agents, CONTINUUM: Lifelong Learning in Neurology, 2011, 17, 95

    CrossRef

  46. 46
    Miki Takeshita, Yoshiko Banno, Mitsuhiro Nakamura, Mayuko Otsuka, Hitomi Teramachi, Teruo Tsuchiya, Yoshinori Itoh, The Pivotal Role of Intracellular Calcium in Oxaliplatin-Induced Inhibition of Neurite Outgrowth but Not Cell Death in Differentiated PC12 Cells, Chemical Research in Toxicology, 2011, 24, 11, 1845

    CrossRef

  47. 47
    Hadi Manji, Toxic neuropathy, Current Opinion in Neurology, 2011, 24, 5, 484

    CrossRef

  48. 48
    Susanna B. Park, Cindy S.-Y. Lin, Arun V. Krishnan, David Goldstein, Michael L. Friedlander, Matthew C. Kiernan, Utilizing natural activity to dissect the pathophysiology of acute oxaliplatin-induced neuropathy, Experimental Neurology, 2011, 227, 1, 120

    CrossRef

  49. 49
    Badreldin H. Ali, Amelioration of Oxaliplatin Neurotoxicity by Drugs in Humans and Experimental Animals: A MiniReview of Recent Literature, Basic & Clinical Pharmacology & Toxicology, 2010, 106, 4
  50. 50
    Joleen Hubbard, Axel Grothey, Strategies for Managing Chemotherapy-Induced Sensory Neuropathy, Current Colorectal Cancer Reports, 2010, 6, 3, 126

    CrossRef

  51. 51
    Karen Y. Wonders, Beverly S. Reigle, Daniel G. Drury, Treatment strategies for chemotherapy-induced peripheral neuropathy: potential role of exercise, Oncology Reviews, 2010, 4, 2, 117

    CrossRef

  52. 52
    Paola Milla, Mario Airoldi, Günther Weber, Anne Drescher, Ulrich Jaehde, Luigi Cattel, Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity, Anti-Cancer Drugs, 2009, 20, 5, 396

    CrossRef

  53. 53
    Arun V. Krishnan, Cindy S.-Y. Lin, Susanna B. Park, Matthew C. Kiernan, Axonal ion channels from bench to bedside: A translational neuroscience perspective, Progress in Neurobiology, 2009, 89, 3, 288

    CrossRef

  54. 54
    Elizabeth K. Joseph, Jon D. Levine, Comparison of Oxaliplatin- and Cisplatin-Induced Painful Peripheral Neuropathy in the Rat, The Journal of Pain, 2009, 10, 5, 534

    CrossRef

  55. 55
    Carlos Belmonte, James A. Brock, Felix Viana, Converting cold into pain, Experimental Brain Research, 2009, 196, 1, 13

    CrossRef

  56. 56
    David Schiff, Patrick Y. Wen, Martin J. van den Bent, Neurological adverse effects caused by cytotoxic and targeted therapies, Nature Reviews Clinical Oncology, 2009, 6, 10, 596

    CrossRef

  57. 57
    S. B. Park, C. S.-Y. Lin, A. V. Krishnan, D. Goldstein, M. L. Friedlander, M. C. Kiernan, Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy, Brain, 2009, 132, 10, 2712

    CrossRef

  58. 58
    N. Attal, D. Bouhassira, M. Gautron, J. N. Vaillant, E. Mitry, C. Lepère, P. Rougier, F. Guirimand, Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: A prospective quantified sensory assessment study, Pain, 2009, 144, 3, 245

    CrossRef

  59. 59
    Louis H. Weimer, Noor Sachdev, Update on medication-induced peripheral neuropathy, Current Neurology and Neuroscience Reports, 2009, 9, 1, 69

    CrossRef

  60. 60
    Andreas A. Argyriou, Panagiotis Polychronopoulos, Gregoris Iconomou, Elisabeth Chroni, Haralabos P. Kalofonos, A review on oxaliplatin-induced peripheral nerve damage, Cancer Treatment Reviews, 2008, 34, 4, 368

    CrossRef

  61. 61
    Arun V. Krishnan, Cindy S.-Y. Lin, Susanna B. Park, Matthew C. Kiernan, Assessment of nerve excitability in toxic and metabolic neuropathies, Journal of the Peripheral Nervous System, 2008, 13, 1
  62. 62
    Bushra Malik, Mark Stillman, Chemotherapy-induced peripheral neuropathy, Current Neurology and Neuroscience Reports, 2008, 8, 1, 56

    CrossRef

  63. 63
    Bushra Malik, Mark Stillman, Chemotherapy-induced peripheral neuropathy, Current Pain and Headache Reports, 2008, 12, 3, 165

    CrossRef

  64. 64
    Anthony J. Windebank, Wolfgang Grisold, Chemotherapy-induced neuropathy, Journal of the Peripheral Nervous System, 2008, 13, 1
  65. 65
    Bing Ling, François Coudoré, Loic Decalonne, Alain Eschalier, Nicolas Authier, Comparative antiallodynic activity of morphine, pregabalin and lidocaine in a rat model of neuropathic pain produced by one oxaliplatin injection, Neuropharmacology, 2008, 55, 5, 724

    CrossRef

  66. 66
    A. Lagueny, A. Vital, Neuropathies toxiques, EMC - Neurologie, 2008, 5, 2, 1

    CrossRef

  67. 67
    A. Lagueny, A. Vital, Neuropatie tossiche, EMC - Neurologia, 2008, 8, 4, 1

    CrossRef

  68. 68
    Elizabeth K. Joseph, Xiaojie Chen, Oliver Bogen, Jon D. Levine, Oxaliplatin Acts on IB4-Positive Nociceptors to Induce an Oxidative Stress-Dependent Acute Painful Peripheral Neuropathy, The Journal of Pain, 2008, 9, 5, 463

    CrossRef

  69. 69
    T. Kowalski, C. Maier, A. Reinacher-Schick, U. Schlegel, Schmerzhaftes Hyperexzitabilitätssyndrom unter Oxaliplatin-haltiger Chemotherapie, Der Schmerz, 2008, 22, 1, 16

    CrossRef

  70. 70
    Muhammad Wasif Saif, Shahrukh Hashmi, Successful amelioration of oxaliplatin-induced hyperexcitability syndrome with the antiepileptic pregabalin in a patient with pancreatic cancer, Cancer Chemotherapy and Pharmacology, 2008, 61, 3, 349

    CrossRef

  71. 71
    Alexia Kagiava, Anastasia Tsingotjidou, Christos Emmanouilides, George Theophilidis, The effects of oxaliplatin, an anticancer drug, on potassium channels of the peripheral myelinated nerve fibres of the adult rat, NeuroToxicology, 2008, 29, 6, 1100

    CrossRef

  72. 72
    Gigi J. Ebenezer, Peter Hauer, Christopher Gibbons, Justin C. McArthur, Michael Polydefkis, Assessment of Epidermal Nerve Fibers, Journal of Neuropathology and Experimental Neurology, 2007, 66, 12, 1059

    CrossRef

  73. 73
    Bing Ling, Marie-Ange Coudoré-Civiale, David Balayssac, Alain Eschalier, François Coudoré, Nicolas Authier, Behavioral and immunohistological assessment of painful neuropathy induced by a single oxaliplatin injection in the rat, Toxicology, 2007, 234, 3, 176

    CrossRef

  74. 74
    Melanie Walker, Oliver Ni, Neuroprotection During Chemotherapy, American Journal of Clinical Oncology, 2007, 30, 1, 82

    CrossRef

  75. 75
    George P Kim, Charles Erlichman, Oxaliplatin in the treatment of colorectal cancer, Expert Opinion on Drug Metabolism & Toxicology, 2007, 3, 2, 281

    CrossRef

  76. 76
    Andreas Binder, Maike Stengel, Rainer Maag, Gunnar Wasner, Robert Schoch, Frank Moosig, Bernhard Schommer, Ralf Baron, Pain in oxaliplatin-induced neuropathy – Sensitisation in the peripheral and central nociceptive system, European Journal of Cancer, 2007, 43, 18, 2658

    CrossRef

  77. 77
    Gail Wilkes, Peripheral Neuropathy Related to Chemotherapy, Seminars in Oncology Nursing, 2007, 23, 3, 162

    CrossRef

  78. 78
    Matthew C. Kiernan, The pain with platinum: Oxaliplatin and neuropathy, European Journal of Cancer, 2007, 43, 18, 2631

    CrossRef

  79. 79
    John W. Scadding, Martin Koltzenburg, Wall y Melzack. Tratado del Dolor, 2007,

    CrossRef

  80. 80
    Amanda C Peltier, James W Russell, Advances in Understanding Drug-Induced Neuropathies, Drug Safety, 2006, 29, 1, 23

    CrossRef

  81. 81
    Jane Choi, Kevin Kong, Tahseen Mozaffar, Randall F. Holcombe, Delayed oxaliplatin-associated neurotoxicity following adjuvant chemotherapy for stage III colon cancer, Anti-Cancer Drugs, 2006, 17, 1, 103

    CrossRef

  82. 82
    Mark Stillman, Juan P. Cata, Management of chemotherapy-induced peripheral neuropathy, Current Pain and Headache Reports, 2006, 10, 4, 279

    CrossRef

  83. 83
    Peng-Chan Lin, Ming-Yang Lee, Wei-Shu Wang, Chueh-Chuan Yen, Ta-Chung Chao, Liang-Tsai Hsiao, Muh-Hwa Yang, Po-Min Chen, Kon-Ping Lin, Tzeon-Jye Chiou, N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data, Supportive Care in Cancer, 2006, 14, 5, 484

    CrossRef

  84. 84
    Robert Cavaliere, David Schiff, Neurologic toxicities of cancer therapies, Current Neurology and Neuroscience Reports, 2006, 6, 3, 218

    CrossRef

  85. 85
    Paul Maddison, Neuromyotonia, Clinical Neurophysiology, 2006, 117, 10, 2118

    CrossRef

  86. 86
    Rainer Maag, Ralf Baron, Neuropathic Pain: Translational research and impact for patient care, Current Pain and Headache Reports, 2006, 10, 3, 191

    CrossRef

  87. 87
    Lauren E. Ta, Laura Espeset, Jewel Podratz, Anthony J. Windebank, Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum–DNA binding, NeuroToxicology, 2006, 27, 6, 992

    CrossRef

  88. 88
    Ana-Maria Florea, Dietrich Büsselberg, Occurrence, use and potential toxic effects of metals and metal compounds, BioMetals, 2006, 19, 4, 419

    CrossRef

  89. 89
    Lara Maria Pasetto, Mario Rosario D’Andrea, Elena Rossi, Silvio Monfardini, Oxaliplatin-related neurotoxicity: How and why?, Critical Reviews in Oncology/Hematology, 2006, 59, 2, 159

    CrossRef

  90. 90
    Wolfram Goessling, Robert J. Mayer, Systemic Treatment of Patients Who Have Colorectal Cancer and Inflammatory Bowel Disease, Gastroenterology Clinics of North America, 2006, 35, 3, 713

    CrossRef

  91. 91
    John W. Scadding, Martin Koltzenburg, Wall and Melzack's Textbook of Pain, 2006,

    CrossRef

  92. 92
    Axel Grothey, Clinical Management of Oxaliplatin-Associated Neurotoxicity, Clinical Colorectal Cancer, 2005, 5, S38

    CrossRef

  93. 93
    G. Kesava Reddy, Tara Beers Gibson, Susan Peck, Preeta Tyagi, Edward Chu, Sara Mariani, Highlights From: The American Society of Clinical Oncology Gastrointestinal Cancers Symposium; Hollywood, FL January 2005, Clinical Colorectal Cancer, 2005, 4, 6, 367

    CrossRef

  94. 94
    Pamela Z. New, NEUROLOGICAL COMPLICATIONS OF CHEMOTHERAPEUTIC AND BIOLOGICAL AGENTS, CONTINUUM: Lifelong Learning in Neurology, 2005, 11, 116

    CrossRef

  95. 95
    SMF Jamieson, J Liu, B Connor, MJ McKeage, Oxaliplatin causes selective atrophy of a subpopulation of dorsal root ganglion neurons without inducing cell loss, Cancer Chemotherapy and Pharmacology, 2005, 56, 4, 391

    CrossRef

  96. 96
    Richard G Webster, Keith L Brain, Richard H Wilson, Jean L Grem, Angela Vincent, Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage-gated sodium channels, British Journal of Pharmacology, 2005, 146, 7
  97. 97
    Arun V. Krishnan, David Goldstein, Michael Friedlander, Matthew C. Kiernan, Oxaliplatin-induced neurotoxicity and the development of neuropathy, Muscle & Nerve, 2005, 32, 1
  98. 98
    Thierry Kuntzer, Jean-Christophe Antoine, Andreas J. Steck, Clinical features and pathophysiological basis of sensory neuronopathies (ganglionopathies), Muscle & Nerve, 2004, 30, 3
  99. 99
    Gregory D. Leonard, Michael R. Wagner, Mary G. Quinn, Jean L. Grem, Severe disabling sensory-motor polyneuropathy during oxaliplatin-based chemotherapy, Anti-Cancer Drugs, 2004, 15, 7, 733

    CrossRef

  100. 100
    Sebastian Brandner, Toxic neuropathies,